Nanjing, China · Founded 2019 · Privately Held (backing)
Manufacturer of mRNA vaccine drugs designed to treat infectious diseases and cancers. TheraRNA is based in Nanjing, China and was founded in 2019. Its last reported valuation was $27.9 million in Dec 2022. It has raised $6.4 million.
Last reported valuation
$27.9M
Oct 2026
Priced at
—
Total raised
$6.4M
Last round
—
Cap table — not yet on record
TheraRNA's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of TheraRNA with a free account
·Watch TheraRNA: the Monday email on marks, rounds and moves
